Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cafiero

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Tumori|October 4, 2000
Mapping the sentinel lymph node in malignant melanoma by blue dye, lymphoscintigraphy and intraoperative gamma probeG Villa, G Agnese, P Bianchi, et al.
In Vivo (Athens, Greece)|December 18, 2010
Regeneration of mandibular osteoradionecrosis defect with platelet rich plasma gelM Scala, M Gipponi, P Mereu, et al.
Minerva Chirurgica|January 1, 1994
[Perioperative teicoplanin prophylaxis in patients undergoing breast reconstruction with the abdominal wall. A case-control study]S Franchelli, M S Leone, E Vigna, et al.
Minerva Chirurgica|June 30, 1986
[Clinico-microbiological investigation in septic complications after gastrointestinal surgery. A multicenter study]M Battezzati, E Berti Riboli, F Cafiero, et al.
Minerva Ginecologica|October 1, 1984
[Biological and clinical evaluation of 114 cases of cancer of the breast]F Badellino, G Canavese, G Margarino, et al.
Oncology Reports|May 19, 2011
Analysis of the proliferative and phenotypic properties of tumor infiltrating lymphocytes expanded in vitro in the course of the clinical trial of adoptive immunotherapy of metastatic melanomaG Pietra, C Semino, S Basso, et al.
Annals of Surgical Oncology|May 26, 1999
Adoptive immunotherapy with tumor-infiltrating lymphocytes and subcutaneous recombinant interleukin-2 plus interferon alfa-2a for melanoma patients with nonresectable distant disease: a phase I/II pilot trial. Melanoma Istituto Scientifico Tumori GroupP Queirolo, M Ponte, M Gipponi, et al.
Melanoma Research|August 28, 1999
Intercellular adhesion molecule-1 (ICAM-1) and granulocyte-macrophage colony stimulating factor (GM-CSF) co-expression in cutaneous malignant melanoma lesionsP Ciotti, G P Pesce, F Cafiero, et al.
Anticancer Research|April 12, 2012
A two-step selection of breast cancer patients candidates for exclusive IORT with electrons: a mono-institutional experienceM Guenzi, A Fozza, G Timon, et al.
Tumori|October 9, 2002
The role of sentinel lymph node biopsy in patients with stage I/II cutaneous melanoma. The clinical experience at the National Cancer Research Institute of Genoa, ItalyF Cafiero, M Gipponi, C Di Somma, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Tumori|October 4, 2000
Mapping the sentinel lymph node in malignant melanoma by blue dye, lymphoscintigraphy and intraoperative gamma probeG Villa, G Agnese, P Bianchi, et al.
In Vivo (Athens, Greece)|December 18, 2010
Regeneration of mandibular osteoradionecrosis defect with platelet rich plasma gelM Scala, M Gipponi, P Mereu, et al.
Minerva Chirurgica|January 1, 1994
[Perioperative teicoplanin prophylaxis in patients undergoing breast reconstruction with the abdominal wall. A case-control study]S Franchelli, M S Leone, E Vigna, et al.
Minerva Chirurgica|June 30, 1986
[Clinico-microbiological investigation in septic complications after gastrointestinal surgery. A multicenter study]M Battezzati, E Berti Riboli, F Cafiero, et al.
Minerva Ginecologica|October 1, 1984
[Biological and clinical evaluation of 114 cases of cancer of the breast]F Badellino, G Canavese, G Margarino, et al.
Oncology Reports|May 19, 2011
Analysis of the proliferative and phenotypic properties of tumor infiltrating lymphocytes expanded in vitro in the course of the clinical trial of adoptive immunotherapy of metastatic melanomaG Pietra, C Semino, S Basso, et al.
Annals of Surgical Oncology|May 26, 1999
Adoptive immunotherapy with tumor-infiltrating lymphocytes and subcutaneous recombinant interleukin-2 plus interferon alfa-2a for melanoma patients with nonresectable distant disease: a phase I/II pilot trial. Melanoma Istituto Scientifico Tumori GroupP Queirolo, M Ponte, M Gipponi, et al.
Melanoma Research|August 28, 1999
Intercellular adhesion molecule-1 (ICAM-1) and granulocyte-macrophage colony stimulating factor (GM-CSF) co-expression in cutaneous malignant melanoma lesionsP Ciotti, G P Pesce, F Cafiero, et al.
Anticancer Research|April 12, 2012
A two-step selection of breast cancer patients candidates for exclusive IORT with electrons: a mono-institutional experienceM Guenzi, A Fozza, G Timon, et al.
Tumori|October 9, 2002
The role of sentinel lymph node biopsy in patients with stage I/II cutaneous melanoma. The clinical experience at the National Cancer Research Institute of Genoa, ItalyF Cafiero, M Gipponi, C Di Somma, et al.
Pageof 9